Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
224.75
-7.81 (-3.36%)
Official Closing Price
Updated: 7:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Charles River Laboratories Intl
< Previous
1
2
3
4
5
6
7
Next >
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
January 09, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors
December 06, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection
December 01, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program
November 28, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at November Investor Conferences
November 14, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022
November 10, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
November 07, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Third-Quarter 2022 Results
November 02, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
October 18, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
October 11, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
October 10, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
September 08, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
September 06, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Expands Contract Vivarium Space on West Coast
August 23, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product
August 09, 2022
From
Charles River Laboratories, International Inc.
Via
Business Wire
Charles River Laboratories Announces Second-Quarter 2022 Results
August 03, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
July 11, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
June 28, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
June 23, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
June 13, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
June 06, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces First-Quarter 2022 Results
May 04, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
April 27, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
April 13, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
April 07, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Acquires Explora BioLabs
April 06, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
March 28, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
February 16, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Wind Contract with Repsol for European Operations
February 03, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Expands Strategic Partnership With SAMDI Tech
January 27, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.